Clinical Trial Update: Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for Nexavar as neoadjuvant treatment in anaplastic thyroid cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Cancer

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Fujian Medical University | Conditions: Thyroid Cancer, Anaplastic | Phase 2 | Status: COMPLETED